Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bupropion and other non-nicotine pharmacotherapies.

× No keyword cloud information.

3 in total

1. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Authors: D E Jorenby; S J Leischow; M A Nides; S I Rennard; J A Johnston; A R Hughes; S S Smith; M L Muramoto; D M Daughton; K Doan; M C Fiore; T B Baker
Journal: N Engl J Med Date: 1999-03-04 Impact factor: 91.245

2. A comparison of sustained-release bupropion and placebo for smoking cessation.

Authors: R D Hurt; D P Sachs; E D Glover; K P Offord; J A Johnston; L C Dale; M A Khayrallah; D R Schroeder; P N Glover; C R Sullivan; I T Croghan; P M Sullivan
Journal: N Engl J Med Date: 1997-10-23 Impact factor: 91.245

Review 3. Antidepressants for smoking cessation.

Authors: J R Hughes; L F Stead; T Lancaster
Journal: Cochrane Database Syst Rev Date: 2003

3 in total

15 in total

1. Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand.

Authors: Mira Harrison-Woolrych; Simran Maggo; Ming Tan; Ruth Savage; Janelle Ashton
Journal: Drug Saf Date: 2012-01-01 Impact factor: 5.606

Review 2. Smoking cessation.

Authors: Prasima Srivastava; Graeme P Currie; John Britton
Journal: BMJ Date: 2006-06-03

3. Prolonged oro-facial dystonia in a 58 year old female following therapy with bupropion and St John's Wort.

Authors: James C Milton; Aza Abdulla
Journal: Br J Clin Pharmacol Date: 2007-06-19 Impact factor: 4.335

4. Efficacy of bupropion in the indigenous Maori population in New Zealand.

Authors: S Holt; C Timu-Parata; S Ryder-Lewis; M Weatherall; R Beasley
Journal: Thorax Date: 2005-02 Impact factor: 9.139

Review 5. Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators.

Authors: N Vanattou-Saïfoudine; R McNamara; A Harkin
Journal: Br J Pharmacol Date: 2012-11 Impact factor: 8.739

6. Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review.

Authors: Carlotta Lunghi; Michèle Dugas; Jacinthe Leclerc; Elisabetta Poluzzi; Cathy Martineau; Valérie Carnovale; Théo Stéfan; Patrick Blouin; Johanie Lépine; Laura Jalbert; Nataly R Espinoza Suarez; Olha Svyntozelska; Marie-Pier Dery; Giraud Ekanmian; Daniele Maria Nogueira; Pelumi Samuel Akinola; Stéphane Turcotte; Becky Skidmore; Annie LeBlanc
Journal: BMJ Open Date: 2022-05-31 Impact factor: 3.006

7. Predictors of marked weight gain in a population of health care and industrial workers following smoking cessation.

Authors: Andreas Scherr; Bruno Seifert; Martin Kuster; Anja Meyer; Karl-Olov Fagerstroem; Michael Tamm; Daiana Stolz
Journal: BMC Public Health Date: 2015-05-30 Impact factor: 3.295

Review 8. Smoking cessation therapy with varenicline.

Authors: Uma M Mohanasundaram; Rajinder Chitkara; Ganesh Krishna
Journal: Int J Chron Obstruct Pulmon Dis Date: 2008

9. Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic.

Authors: Elif Yilmazel Ucar; Omer Araz; Nafiye Yilmaz; Metin Akgun; Mehmet Meral; Hasan Kaynar; Leyla Saglam
Journal: Multidiscip Respir Med Date: 2014-02-04

Review 10. Pharmacological intervention of nicotine dependence.

Authors: Raka Jain; Pradipta Majumder; Tina Gupta
Journal: Biomed Res Int Date: 2013-12-29 Impact factor: 3.411